The stock of PharmaCan Capital Corp (CVE:MJN) is a huge mover today! About 569,949 shares traded hands. PharmaCan Capital Corp (CVE:MJN) has risen 6.00% since October 23, 2016 and is uptrending. It has outperformed by 1.44% the S&P500.
The move comes after 9 months negative chart setup for the $215.54M company. It was reported on Nov, 22 by Barchart.com. We have $1.43 PT which if reached, will make CVE:MJN worth $10.78 million less.
More important recent PharmaCan Capital Corp (CVE:MJN) news were published by: Marketwatch.com which released: “Jason Adler Announces Increase in Equity Interest in PharmaCan Capital Corp.” on June 08, 2016, also Midasletter.com published article titled: “PharmaCan Capital Corp (TSX.V:MJN) CEO Paul Rosen Interview and Podcast”, Marketwired.com published: “PharmaCan Capital Corp. to Open Toronto Stock Exchange” on January 13, 2015. More interesting news about PharmaCan Capital Corp (CVE:MJN) was released by: Marketwired.com and their article: “PharmaCan Capital Corp. Announces Approval of Increased Production Expansion …” with publication date: April 01, 2015.
PharmaCan Capital Corp., formerly Searchtech Ventures Inc., is a merchant bank, which is focused on investing in Canada’s medical marijuana industry. The company has a market cap of $215.54 million. The Firm is engaged in the business of investing in companies either licensed or seeking a license to produce medical marijuana. It currently has negative earnings. The Firm operates through two divisions: Investing Segment and Operating Segment.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.